These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31684751)

  • 1. Loperamide toxicity: recommendations for patient monitoring and management.
    Eggleston W; Palmer R; Dubé PA; Thornton S; Stolbach A; Calello DP; Marraffa JM
    Clin Toxicol (Phila); 2020 May; 58(5):355-359. PubMed ID: 31684751
    [No Abstract]   [Full Text] [Related]  

  • 2. Loperamide Trends in Abuse and Misuse Over 13 Years: 2002-2015.
    Lasoff DR; Koh CH; Corbett B; Minns AB; Cantrell FL
    Pharmacotherapy; 2017 Feb; 37(2):249-253. PubMed ID: 27995643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notes from the Field: Cardiac Dysrhythmias After Loperamide Abuse - New York, 2008-2016.
    Eggleston W; Marraffa JM; Stork CM; Mercurio-Zappala M; Su MK; Wightman RS; Cummings KR; Schier JG
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(45):1276-1277. PubMed ID: 27855148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loperamide-Associated Opioid Use Disorder and Proposal of an Alternative Treatment with Buprenorphine.
    Wolfrum LA; Nordmeyer AS; Racine CW; Nichols SD
    J Addict Med; 2019; 13(3):245-247. PubMed ID: 30379781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse.
    Swank KA; Wu E; Kortepeter C; McAninch J; Levin RL
    J Am Pharm Assoc (2003); 2017; 57(2S):S63-S67. PubMed ID: 28073687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loperamide Abuse and Dependence: Clinical Features and Treatment Considerations.
    Okusanya A; Li X
    J Addict Med; 2018; 12(6):496-498. PubMed ID: 30067552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic Trends in Loperamide Abuse and Misuse.
    Vakkalanka JP; Charlton NP; Holstege CP
    Ann Emerg Med; 2017 Jan; 69(1):73-78. PubMed ID: 27823872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loperamide Abuse Associated With Cardiac Dysrhythmia and Death.
    Eggleston W; Clark KH; Marraffa JM
    Ann Emerg Med; 2017 Jan; 69(1):83-86. PubMed ID: 27140747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brugada-Type Pattern on Electrocardiogram Associated with High-Dose Loperamide Abuse.
    Sun C; Brice JA; Clark RF
    J Emerg Med; 2018 Apr; 54(4):484-486. PubMed ID: 29439890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loperamide misuse and abuse.
    Miller H; Panahi L; Tapia D; Tran A; Bowman JD
    J Am Pharm Assoc (2003); 2017; 57(2S):S45-S50. PubMed ID: 28189538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loperamide misuse to avoid opioid withdrawal and to achieve a euphoric effect: high doses and high risk.
    Lee VR; Vera A; Alexander A; Ruck B; Nelson LS; Wax P; Campleman S; Brent J; Calello DP
    Clin Toxicol (Phila); 2019 Mar; 57(3):175-180. PubMed ID: 30585509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intentional Misuse and Abuse of Loperamide: A New Look at a Drug with "Low Abuse Potential".
    Borron SW; Watts SH; Tull J; Baeza S; Diebold S; Barrow A
    J Emerg Med; 2017 Jul; 53(1):73-84. PubMed ID: 28501383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic.
    Kang J; Compton DR; Vaz RJ; Rampe D
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1133-7. PubMed ID: 27530870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loperamide, the "Poor Man's Methadone": Brief Review.
    Stanciu CN; Gnanasegaram SA
    J Psychoactive Drugs; 2017; 49(1):18-21. PubMed ID: 27918873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loperamide abuse cardiotoxicity. Should loperamide still be an over the counter medication?
    Idris A; Mihora DC; Kaye K
    Am J Emerg Med; 2018 Sep; 36(9):1716.e1-1716.e3. PubMed ID: 29779679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Review: Loperamide Toxicity.
    Wu PE; Juurlink DN
    Ann Emerg Med; 2017 Aug; 70(2):245-252. PubMed ID: 28506439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of overdoses of loperamide, gabapentin, and modafinil: a literature review.
    Reinert JP; Dunn RL
    Expert Rev Clin Pharmacol; 2019 Sep; 12(9):901-908. PubMed ID: 31422705
    [No Abstract]   [Full Text] [Related]  

  • 18. Loperamide Cardiac Toxicity: Pathophysiology, Presentation, and Management.
    Wu PE; Juurlink DN
    Can J Cardiol; 2022 Sep; 38(9):1378-1383. PubMed ID: 35430193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loperamide dependence and abuse.
    MacDonald R; Heiner J; Villarreal J; Strote J
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25935922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysrhythmias with Loperamide Used for Opioid Withdrawal.
    Vithalani ND; Heron C; Rao RE; Cardell AF; Stephens MB
    J Am Board Fam Med; 2017; 30(6):832-834. PubMed ID: 29180560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.